MYMD Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)1holders
$2.39avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding MYMD Pharmaceuticals Inc. in their 13F filings. The largest holder was St. Johns Investment Management Company, LLC ($43).
- Company
- MYMD Pharmaceuticals Inc.
- CUSIP
- 62856X102
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 30 | $377K |
Ownership 1 holders
| St. Johns Investment Management Company, LLC | 0.00% | Reduce -96.4% | 18 | $43 |
"% of holder's portfolio" is MYMD PHARMACEUTICALS INC's weight in each manager's 13F, not the share of MYMD Pharmaceuticals Inc. the manager owns.